Scholarlink

<p>Membrane-bound neuropilin-1 (Nrp-1) has been implicated as a regulator of insulin resistance-related lipid metabolism, but little is known about its circulating form, soluble Nrp-1 (sNrp-1), in a metabolic context. Here we investigated the association between plasma levels of sNrp-1 and metabolic variables in 501 participants from the Prospective investigation of Obesity, Energy and Metabolism (POEM) study. Metabolic phenotyping included blood sampling, dual energy X-ray absorptiometry scan, magnetic resonance imaging for fat distribution, and a glucose tolerance test. Associations were examined using linear regression models and Spearman’s rank correlation. Plasma sNrp-1 levels were inversely associated with levels of total fatty acids, triglycerides and lactate, and positively associated with markers of insulin sensitivity. In human Simpson-Golabi-Behmel Syndrome (SGBS) adipocytes, we showed that treatment with recombinant Nrp-1 reduced phosphorylation of hormone-sensitive lipase in the basal state and attenuated isoproterenol-stimulated glycerol release, a measure of total lipolytic activity. Based on these findings, we thus postulate that sNrp-1-mediated suppression of lipolysis could explain our observed association between plasma sNrp-1 and a favorable lipid profile in humans. Further studies are warranted to establish causality and to clarify the role of sNrp-1 in promoting insulin sensitivity in human adipose tissue.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Plasma neuropilin-1 is associated with a favorable lipid profile and insulin sensitivity in a population-based sample of 50-year-old individuals

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年8月5日

查看全文
  • Emanuel Fryk,
  • Vagner Ramon Rodrigues Silva,
  • Marco Bauzá-Thorbrügge,
  • Lena Strindberg,
  • Joel Kullberg,
  • Håkan Ahlström,
  • Martin Wabitsch,
  • Pamela Fischer-Posovszky,
  • Rosie Perkins,
  • Milica Vujicic,
  • Ingrid Wernstedt Asterholm,
  • Lars Lind,
  • Per-Anders Jansson

摘要

Membrane-bound neuropilin-1 (Nrp-1) has been implicated as a regulator of insulin resistance-related lipid metabolism, but little is known about its circulating form, soluble Nrp-1 (sNrp-1), in a metabolic context. Here we investigated the association between plasma levels of sNrp-1 and metabolic variables in 501 participants from the Prospective investigation of Obesity, Energy and Metabolism (POEM) study. Metabolic phenotyping included blood sampling, dual energy X-ray absorptiometry scan, magnetic resonance imaging for fat distribution, and a glucose tolerance test. Associations were examined using linear regression models and Spearman’s rank correlation. Plasma sNrp-1 levels were inversely associated with levels of total fatty acids, triglycerides and lactate, and positively associated with markers of insulin sensitivity. In human Simpson-Golabi-Behmel Syndrome (SGBS) adipocytes, we showed that treatment with recombinant Nrp-1 reduced phosphorylation of hormone-sensitive lipase in the basal state and attenuated isoproterenol-stimulated glycerol release, a measure of total lipolytic activity. Based on these findings, we thus postulate that sNrp-1-mediated suppression of lipolysis could explain our observed association between plasma sNrp-1 and a favorable lipid profile in humans. Further studies are warranted to establish causality and to clarify the role of sNrp-1 in promoting insulin sensitivity in human adipose tissue.